Acrivon Therapeutics, Inc. Common Stock Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 8.34 M | $16.93 M | 0.00% | 21.81% |
PERCEPTIVE ADVISORS LLC | 05/15/2025 | 5.36 M | $10.88 M | 0.00% | 14.02% |
SANDS CAPITAL VENTURES, LLC | 05/14/2025 | 2.12 M | $4.31 M | 0.00% | 5.53% |
CITADEL ADVISORS LLC | 05/15/2025 | 1.90 M | $3.85 M | -10.57% | 4.94% |
BLACKROCK, INC. | 05/02/2025 | 938.71 K | $1.91 M | -0.72% | 2.45% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 888.13 K | $1.80 M | 0.00% | 2.32% |
VANGUARD GROUP INC | 05/09/2025 | 674.79 K | $1.37 M | 0.47% | 1.76% |
MARSHALL WACE, LLP | 05/15/2025 | 450.39 K | $914.29 K | -24.66% | 1.17% |
05/19/2025 | 405.24 K | $822.63 K | 0.00% | 1.06% | |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 306.11 K | $621.58 K | 1.57% | 0.80% |
STATE STREET CORP | 05/15/2025 | 232.55 K | $472.08 K | -1.71% | 0.61% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 111.32 K | $225.98 K | -2.21% | 0.29% |
NORTHERN TRUST CORP | 05/13/2025 | 109.03 K | $221.32 K | -7.07% | 0.28% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 77.90 K | $158.14 K | 4.42% | 0.20% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 57.52 K | $116.76 K | -75.79% | 0.15% |
05/13/2025 | 56.47 K | $114.63 K | 420.10% | 0.15% | |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 52.10 K | $105.76 K | 5.47% | 0.14% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 44.15 K | $89.99 K | 19.13% | 0.12% |
INVESCO LTD. | 05/12/2025 | 35.32 K | $71.69 K | 100.00% | 0.09% |
MORGAN STANLEY | 05/15/2025 | 35.22 K | $71.50 K | 1.41% | 0.09% |
BARCLAYS PLC | 05/15/2025 | 32.70 K | $66.00 K | -14.16% | 0.09% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 27.70 K | $56.23 K | -10.95% | 0.07% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 27.64 K | $56.10 K | 0.00% | 0.07% |
EXCHANGE TRADED CONCEPTS, LLC | 04/17/2025 | 23.16 K | $47.02 K | 13.82% | 0.06% |
BAKER BROS. ADVISORS LP | 05/15/2025 | 22.81 K | $46.30 K | -56.87% | 0.06% |
AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 17.38 K | $35.28 K | -1.18% | 0.05% |
RHUMBLINE ADVISERS | 05/29/2025 | 16.60 K | $33.69 K | -6.51% | 0.04% |
UBS OCONNOR LLC | 05/15/2025 | 15.58 K | $31.62 K | -84.85% | 0.04% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 14.58 K | $29.60 K | 100.00% | 0.04% |
05/12/2025 | 13.40 K | $27.21 K | 100.00% | 0.03% | |
PRELUDE CAPITAL MANAGEMENT, LLC | 05/15/2025 | 13.07 K | $26.53 K | 100.00% | 0.03% |
UBS GROUP AG | 05/13/2025 | 12.89 K | $26.16 K | -9.35% | 0.03% |
CITIGROUP INC | 05/12/2025 | 11.16 K | $22.65 K | -9.51% | 0.03% |
AAF WEALTH MANAGEMENT, LLC | 05/16/2025 | 10.68 K | $21.68 K | 0.00% | 0.03% |
INTECH INVESTMENT MANAGEMENT LLC | 05/20/2025 | 10.09 K | $20.49 K | 100.00% | 0.03% |
JPMORGAN CHASE & CO | 05/12/2025 | 8.48 K | $17.21 K | -67.15% | 0.02% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 7.09 K | $14.39 K | 2.26% | 0.02% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 7.09 K | $14.39 K | 4.61% | 0.02% |
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 04/30/2025 | 6.25 K | $12.68 K | -5.41% | 0.02% |
COREBRIDGE FINANCIAL, INC. | 05/14/2025 | 5.79 K | $11.75 K | -1.46% | 0.02% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 3.09 K | $6.27 K | 74.97% | 0.01% |
FMR LLC | 05/12/2025 | 2.67 K | $5.41 K | -9.14% | 0.01% |
NEW YORK STATE COMMON RETIREMENT FUND | 05/01/2025 | 2.31 K | $5.00 K | 0.00% | 0.01% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 1.34 K | $2.71 K | -31.17% | 0.00% |
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 04/24/2025 | 1.04 K | $2.33 K | 0.39% | 0.00% |
NISA INVESTMENT ADVISORS, LLC | 04/30/2025 | 959 | $1.95 K | 859.00% | 0.00% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 05/15/2025 | 856 | $1.74 K | 0.00% | 0.00% |
ROYAL BANK OF CANADA | 05/15/2025 | 849 | $2.00 K | -48.17% | 0.00% |
LEGAL & GENERAL GROUP PLC | 05/15/2025 | 839 | $1.70 K | 0.00% | 0.00% |
STRS OHIO | 05/28/2025 | 800 | $1.62 K | 0.00% | 0.00% |
Acrivon Therapeutics, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 62 institutional investors and hedge funds held shares of Acrivon Therapeutics, Inc. Common Stock. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 8.34 M
PERCEPTIVE ADVISORS LLC: 5.36 M
Sands Capital Ventures, LLC: 2.12 M
CITADEL ADVISORS LLC: 1.9 M
BlackRock, Inc.: 938,707
WELLINGTON MANAGEMENT GROUP LLP: 888,130
58.71% of Acrivon Therapeutics, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 23.11 M shares in the last 24 months. This purchase volume represents approximately $27.96 M in transactions.